Autoimmunity in dengue pathogenesis

Shu Wen Wan, Chiou Feng Lin, Trai Ming Yeh, Ching Chuan Liu, Hsiao Sheng Liu, Shuying Wang, Pin Ling, Robert Anderson, Huan Yao Lei, Yee Shin Lin

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Dengue is one of the most important vector-borne viral diseases. With climate change and the convenience of travel, dengue is spreading beyond its usual tropical and subtropical boundaries. Infection with dengue virus (DENV) causes diseases ranging widely in severity, from self-limited dengue fever to life-threatening dengue hemorrhagic fever and dengue shock syndrome. Vascular leakage, thrombocytopenia, and hemorrhage are the major clinical manifestations associated with severe DENV infection, yet the mechanisms remain unclear. Besides the direct effects of the virus, immunopathogenesis is also involved in the development of dengue disease. Antibody-dependent enhancement increases the efficiency of virus infection and may suppress type I interferon-mediated antiviral responses. Aberrant activation of T cells and overproduction of soluble factors cause an increase in vascular permeability. DENV-induced autoantibodies against endothelial cells, platelets, and coagulatory molecules lead to their abnormal activation or dysfunction. Molecular mimicry between DENV proteins and host proteins may explain the cross-reactivity of DENV-induced autoantibodies. Although no licensed dengue vaccine is yet available, several vaccine candidates are under development. For the development of a safe and effective dengue vaccine, the immunopathogenic complications of dengue disease need to be considered.

Original languageEnglish
Pages (from-to)3-11
Number of pages9
JournalJournal of the Formosan Medical Association = Taiwan yi zhi
Volume112
Issue number1
DOIs
Publication statusPublished - Jan 2013
Externally publishedYes

Fingerprint

Dengue Virus
Dengue
Severe Dengue
Autoimmunity
Virus Diseases
Dengue Vaccines
Autoantibodies
Antibody-Dependent Enhancement
Molecular Mimicry
Interferon Type I
Climate Change
Capillary Permeability
Thrombocytopenia
Antiviral Agents
Blood Vessels
Proteins
Blood Platelets
Vaccines
Endothelial Cells
Hemorrhage

Keywords

  • Autoimmunity
  • Dengue
  • Immunopathogenesis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Wan, S. W., Lin, C. F., Yeh, T. M., Liu, C. C., Liu, H. S., Wang, S., ... Lin, Y. S. (2013). Autoimmunity in dengue pathogenesis. Journal of the Formosan Medical Association = Taiwan yi zhi, 112(1), 3-11. https://doi.org/10.1016/j.jfma.2012.11.006

Autoimmunity in dengue pathogenesis. / Wan, Shu Wen; Lin, Chiou Feng; Yeh, Trai Ming; Liu, Ching Chuan; Liu, Hsiao Sheng; Wang, Shuying; Ling, Pin; Anderson, Robert; Lei, Huan Yao; Lin, Yee Shin.

In: Journal of the Formosan Medical Association = Taiwan yi zhi, Vol. 112, No. 1, 01.2013, p. 3-11.

Research output: Contribution to journalArticle

Wan, SW, Lin, CF, Yeh, TM, Liu, CC, Liu, HS, Wang, S, Ling, P, Anderson, R, Lei, HY & Lin, YS 2013, 'Autoimmunity in dengue pathogenesis', Journal of the Formosan Medical Association = Taiwan yi zhi, vol. 112, no. 1, pp. 3-11. https://doi.org/10.1016/j.jfma.2012.11.006
Wan, Shu Wen ; Lin, Chiou Feng ; Yeh, Trai Ming ; Liu, Ching Chuan ; Liu, Hsiao Sheng ; Wang, Shuying ; Ling, Pin ; Anderson, Robert ; Lei, Huan Yao ; Lin, Yee Shin. / Autoimmunity in dengue pathogenesis. In: Journal of the Formosan Medical Association = Taiwan yi zhi. 2013 ; Vol. 112, No. 1. pp. 3-11.
@article{f78ed0eef1d64f3b9e99a9c6bfd387c0,
title = "Autoimmunity in dengue pathogenesis",
abstract = "Dengue is one of the most important vector-borne viral diseases. With climate change and the convenience of travel, dengue is spreading beyond its usual tropical and subtropical boundaries. Infection with dengue virus (DENV) causes diseases ranging widely in severity, from self-limited dengue fever to life-threatening dengue hemorrhagic fever and dengue shock syndrome. Vascular leakage, thrombocytopenia, and hemorrhage are the major clinical manifestations associated with severe DENV infection, yet the mechanisms remain unclear. Besides the direct effects of the virus, immunopathogenesis is also involved in the development of dengue disease. Antibody-dependent enhancement increases the efficiency of virus infection and may suppress type I interferon-mediated antiviral responses. Aberrant activation of T cells and overproduction of soluble factors cause an increase in vascular permeability. DENV-induced autoantibodies against endothelial cells, platelets, and coagulatory molecules lead to their abnormal activation or dysfunction. Molecular mimicry between DENV proteins and host proteins may explain the cross-reactivity of DENV-induced autoantibodies. Although no licensed dengue vaccine is yet available, several vaccine candidates are under development. For the development of a safe and effective dengue vaccine, the immunopathogenic complications of dengue disease need to be considered.",
keywords = "Autoimmunity, Dengue, Immunopathogenesis",
author = "Wan, {Shu Wen} and Lin, {Chiou Feng} and Yeh, {Trai Ming} and Liu, {Ching Chuan} and Liu, {Hsiao Sheng} and Shuying Wang and Pin Ling and Robert Anderson and Lei, {Huan Yao} and Lin, {Yee Shin}",
year = "2013",
month = "1",
doi = "10.1016/j.jfma.2012.11.006",
language = "English",
volume = "112",
pages = "3--11",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Autoimmunity in dengue pathogenesis

AU - Wan, Shu Wen

AU - Lin, Chiou Feng

AU - Yeh, Trai Ming

AU - Liu, Ching Chuan

AU - Liu, Hsiao Sheng

AU - Wang, Shuying

AU - Ling, Pin

AU - Anderson, Robert

AU - Lei, Huan Yao

AU - Lin, Yee Shin

PY - 2013/1

Y1 - 2013/1

N2 - Dengue is one of the most important vector-borne viral diseases. With climate change and the convenience of travel, dengue is spreading beyond its usual tropical and subtropical boundaries. Infection with dengue virus (DENV) causes diseases ranging widely in severity, from self-limited dengue fever to life-threatening dengue hemorrhagic fever and dengue shock syndrome. Vascular leakage, thrombocytopenia, and hemorrhage are the major clinical manifestations associated with severe DENV infection, yet the mechanisms remain unclear. Besides the direct effects of the virus, immunopathogenesis is also involved in the development of dengue disease. Antibody-dependent enhancement increases the efficiency of virus infection and may suppress type I interferon-mediated antiviral responses. Aberrant activation of T cells and overproduction of soluble factors cause an increase in vascular permeability. DENV-induced autoantibodies against endothelial cells, platelets, and coagulatory molecules lead to their abnormal activation or dysfunction. Molecular mimicry between DENV proteins and host proteins may explain the cross-reactivity of DENV-induced autoantibodies. Although no licensed dengue vaccine is yet available, several vaccine candidates are under development. For the development of a safe and effective dengue vaccine, the immunopathogenic complications of dengue disease need to be considered.

AB - Dengue is one of the most important vector-borne viral diseases. With climate change and the convenience of travel, dengue is spreading beyond its usual tropical and subtropical boundaries. Infection with dengue virus (DENV) causes diseases ranging widely in severity, from self-limited dengue fever to life-threatening dengue hemorrhagic fever and dengue shock syndrome. Vascular leakage, thrombocytopenia, and hemorrhage are the major clinical manifestations associated with severe DENV infection, yet the mechanisms remain unclear. Besides the direct effects of the virus, immunopathogenesis is also involved in the development of dengue disease. Antibody-dependent enhancement increases the efficiency of virus infection and may suppress type I interferon-mediated antiviral responses. Aberrant activation of T cells and overproduction of soluble factors cause an increase in vascular permeability. DENV-induced autoantibodies against endothelial cells, platelets, and coagulatory molecules lead to their abnormal activation or dysfunction. Molecular mimicry between DENV proteins and host proteins may explain the cross-reactivity of DENV-induced autoantibodies. Although no licensed dengue vaccine is yet available, several vaccine candidates are under development. For the development of a safe and effective dengue vaccine, the immunopathogenic complications of dengue disease need to be considered.

KW - Autoimmunity

KW - Dengue

KW - Immunopathogenesis

UR - http://www.scopus.com/inward/record.url?scp=84872372074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872372074&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2012.11.006

DO - 10.1016/j.jfma.2012.11.006

M3 - Article

C2 - 23332423

AN - SCOPUS:84872372074

VL - 112

SP - 3

EP - 11

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 1

ER -